To achieve the benefit of cancer screening, appropriate follow-up of abnormal screening test
results must occur. Such follow-up requires traversing the transition between screening …

Timely follow‐up for positive cancer screening results remains suboptimal, and the evidence
base to inform decisions on optimizing the timeliness of diagnostic testing is unclear. This …

Objective: HIV infection and low CD4+ T-cell count are associated with an increased risk of
persistent oncogenic human papillomavirus infection—the major risk factor for cervical …

BACKGROUND. Recent interest in human papillomavirus (HPV)‐associated cancers and
the availability of several years of data covering 83% of the US population prompted this …

Objective Cervical cancer (International Federation of Gynecology and Obstetrics (FIGO))
stage IVA-B (distant stage) is a rare diagnosis with an approximate 5 year survival rate of …

Purpose: This study was designed to determine whether high-resolution anoscopy and
targeted surgical destruction of anal high-grade squamous intraepithelial lesions is effective …

Self‐collection of samples for human papillomavirus (HPV) testing has the potential to
increase the uptake of cervical screening among underscreened women and will likely form …

Background Cervical cancer is a preventable and treatable form of cancer yet continues to
be the fourth most common cancer among women globally. Primary care is the first point of …

Background: Women with breast or cervical cancer abnormalities can experience barriers to
timely follow-up care, resulting in delays in cancer diagnosis. Patient navigation programs …

OBJECTIVES: To review populations of women in the United States at high risk for cervical
cancer, assess known reasons for existing outcome disparities, and discuss potential …